Kineta, Inc., a clinical stage biotechnology company focused on the development of novel immunotherapies in oncology, announced that Kineta’s management team has been invited to participate at H.C. Wainwright Bioconnect Virtual Conference that is being held on January 10-13, 2022.
January 11, 2022
· 1 min read